Allergic-Specific Immunotherapy Using Injectable In Situ Crosslinked Hyaluronic Acid Hydrogels Ameliorates Allergic Response in Murine Allergic Rhinitis Model

被引:0
|
作者
Lee, Hyun Jong [1 ]
Kim, Ji An [2 ]
Lee, Yerin [1 ]
Lim, Saebin [1 ]
Chun, Yoon Hong [2 ]
机构
[1] Gachon Univ, Sch Chem Biol & Battery Engn, Seongnam, South Korea
[2] Catholic Univ Korea, Dept Pediat, Incheon St Marys Hosp, Coll Med, 56 Dongsu Ro, Incheon 21431, South Korea
基金
新加坡国家研究基金会;
关键词
Allergen immunotherapy; allergic rhinitis; house dust mites; hyaluronic acid; hydrogels; RHINOCONJUNCTIVITIS;
D O I
10.4168/aair.2025.17.1.60
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Purpose: We present a convenient and safe allergen-specific immunotherapy using injectable hyaluronic acid (HA) hydrogel containing house dust mite (HDM) crosslinked via visible- light-induced thiol-ene reaction. Methods: We developed 2 types of HDM-containing HA hydrogels, namely thiolated HA (SH-HA) + methacrylated HA (MA-HA) (Gel-1) and 4-arm poly (ethylene glycol) (PEG)-SH + MA-HA (Gel-2). The immunotherapeutic effect of the hydrogels was tested using a murine model of allergic rhinitis. Sensitized mice received 3 subcutaneous injections of the HDM extract (subcutaneous immunotherapy [SCIT] group) or phosphate buffer saline (negative and positive control) at 2-day intervals. Mice in the HA hydrogel immunotherapy groups received one subcutaneous injection of each HA hydrogel precursor solution that formed hydrogel by transmitting blue light through the skin. All except the negative control received HDM extract intranasally for 5 days. Nasal symptoms, ear swelling, eosinophil count, antibody levels, and histopathology of the nasal mucosa were analyzed. Results: All HDM-containing immunotherapy groups exhibited reduced nasal symptoms, ear swelling, and eosinophil count in nasopharyngeal lavage compared to the positive control group. Eosinophils, mast cells, and goblet cells in the nasal mucosa decreased in all treatment groups compared to the positive control group. The serum levels of HDM-specific immunoglobulin G (IgG)1 increased in all treatment groups; however, IgG2a levels increased only in the SCIT and Gel-2 groups. Interleukin (IL)-4, 13, and 17 decreased in all treatment groups compared to those in the positive control group, whereas IL-10level increased only in the SCIT and Gel-2 groups. SCIT and Gel-2 treatment showed similar capability to induce regulatory T cells. Conclusions: Injectable HA hydrogel containing HDM reduced allergic symptoms and induced tolerance in a murine model of allergic rhinitis.
引用
收藏
页码:60 / 76
页数:17
相关论文
共 50 条
  • [21] Efficacy of a house dust mite-induced mouse model for allergen-specific immunotherapy in allergic rhinitis
    Jee, Hye Mi
    ALLERGY ASTHMA & RESPIRATORY DISEASE, 2022, 10 (04): : 187 - 188
  • [22] Development of a house dust mite-induced mouse model for allergen-specific immunotherapy in allergic rhinitis
    Kim, Seok Min
    Kim, Ji An
    Kim, Hwan Soo
    Yoon, Jong-Seo
    Kim, Hyun Hee
    Chun, Yoon Hong
    ALLERGY ASTHMA & RESPIRATORY DISEASE, 2022, 10 (04): : 195 - 201
  • [23] Sublingual administration of liposomes enclosing alpha-galactosylceramide as an effective adjuvant of allergen immunotherapy in a murine model of allergic rhinitis
    Suzuki, Satoshi
    Sakurai, Daiju
    Sakurai, Toshioki
    Yonekura, Syuji
    Iinuma, Tomohisa
    Okuma, Yusuke
    Ihara, Fumie
    Arai, Tomoyuki
    Hanazawa, Toyoyuki
    Fukuda-Kawaguchi, Emi
    Ishii, Yasuyuki
    Okamoto, Yoshitaka
    ALLERGOLOGY INTERNATIONAL, 2019, 68 (03) : 352 - 362
  • [24] Site-specific sensitization in a murine model of allergic rhinitis: Role of the upper airway in lower airways disease
    McCusker, C
    Chicoine, M
    Hamid, Q
    Mazer, B
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2002, 110 (06) : 891 - 898
  • [25] Immunomodulatory Role of Histamine H2 Receptor in Allergen-Specific Immunotherapy: A Mouse Model of Allergic Rhinitis
    Shin, Ji-Hyeon
    Kim, Byung-Guk
    Kim, Sung Won
    Cho, Jin-Hee
    Park, Yong-Jin
    Kim, Soo Whan
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2011, 144 (04) : 500 - 505
  • [26] Blocking antibody is generated in allergic rhinitis patients during specific immunotherapy using standardized Japanese cedar pollen extract
    Kawakami, Ayako
    Koketsu, Rikiya
    Suzukawa, Maho
    Nagao, Mizuho
    Hiraguchi, Yukiko
    Tokuda, Reiko
    Fujisawa, Takao
    Nagase, Hiroyuki
    Ohta, Ken
    Yamamoto, Kazuhiko
    Yamaguchi, Masao
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2008, 146 : 54 - 60
  • [27] Topical CTLA4-lg suppresses ongoing mucosal immune response in presensitized murine model of allergic rhinitis
    Sato, J
    Asakura, K
    Murakami, M
    Uede, T
    Kataura, A
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1999, 119 (03) : 197 - 204
  • [28] Effects of different adjuvants on house dust mite allergy and allergens-specific immunotherapy in a murine model of allergic asthma
    Heldner, A.
    Russkamp, D.
    Alessandrini, F.
    Kramer, M. F.
    Mwange, J.
    Skinner, M.
    Heath, M.
    Schmidt-Weber, C. B.
    Blank, S.
    ALLERGY, 2019, 74 : 322 - 323
  • [29] The hybrid protein BTH2 suppresses allergic airway inflammation in a murine model of HDM-specific immunotherapy
    da Silva, Eduardo Santos
    Rabelo de Santana, Marina Borges
    Silveira, Elisania Fontes
    Torres, Rogerio Tanan
    Silva, Raphael Chagas
    Santana Fernandes, Antonio Marcio
    Medeiros de Andrade Belitardo, Emilia Maria
    Salazar Garces, Luis Fabian
    Santiago, Leonardo Freire
    Ricardo Urrego, Juan
    Vilas-Boas, Deise Souza
    Rodrigues de Freitas, Luiz Antonio
    Zakzuk, Josefina
    Carvalho Pacheco, Luis Gustavo
    Cruz, Alvaro Augusto
    Ferreira, Fatima
    Cooper, Philip
    Caraballo, Luis
    da Silva Pinheiro, Carina
    Alcantara-Neves, Neuza Maria
    CLINICAL AND EXPERIMENTAL ALLERGY, 2023, 53 (08): : 821 - 832
  • [30] Effects of IL-4 receptor a blockade during allergen-specific immunotherapy in a murine model of allergic asthma
    Heine, S.
    Russkamp, D.
    Aguilar-Pimentel, A.
    Alessandrini, F.
    Gailus-Durner, V
    Fuchs, H.
    Ohnmacht, C.
    De Angelis, Hrabe M.
    Ollert, M.
    Schmidt-Weber, C.
    Blank, S.
    ALLERGY, 2019, 74 : 197 - 198